Nelly Tan, MD, and Sean P. Zivin, MD, have been selected by the American Roentgen Ray Society (ARRS) as the recipients of resident travel grants, sponsored by Fujifilm Medical Systems.
To succeed in the future, radiology practices need to transition to a new model characterized by an information mindset with a greatly enhanced radiology product, according to a special report published in the April issue of Radiology.
Imaging amino acid transporters with PET/CT significantly alters intended management plans for patients with brain tumors, according to research in the March issue of The Journal of Nuclear Medicine. As a result of imaging with the radiopharmaceutical 3,4-dihydroxy-6-F-18-fluoro-L-phenylalanine (F-18-DOPA), referring physicians changed the intended management plan for 41 percent of patients with brain tumors.
A team of University of California, Los Angeles scientists who developed a chemical marker to help assess the neurological changes associated with cognitive impairment and dementia have found the brain-imaging tool effectively tracked and predicted cognitive decline over a two-year period, according to a study published in the February issue of Archives of Neurology.
While overall imaging costs are increasing faster than overall Medicare cancer care costs, 18F-FDG PET or PET/CT account for approximately 1.5 percent of Medicare cancer care expenditures, according to an economic analysis published online in a December supplement to the Journal of Nuclear Medicine.
The success of the National Lung Screening Trial (NLST) has not closed the book on lung cancer screening. Instead, it has spurred a host of questions related to overdiagnosis, costs and the potential for other screening methods, according to an article and editorial published Aug. 4 in New England Journal of Medicine. NLST researchers and the editorialist reached the same conclusion: screening CT is not ready for prime time.
Known to be significantly more susceptible to dementia, individuals with Down syndrome appear to display age-related increases in amyloid senile plaques and tau neurofibrillary tangles that mirror those increases in Alzheimer’s patients as viewed with PET, according to a study published in the June issue of Archives of Neurology.
Tuesday, June 7 | 2:30 PM - 4:00 PM
Room 006CD
Saturday, June 4 | 8:00 AM - 12:00 PM
Ballroom C2
Flurpiridaz F 18 injection, a myocardial perfusion imaging (MPI) PET agent, appears to be safe and superior to SPECT with respect to image quality, diagnostic certainty and sensitivity for detection of coronary artery disease (CAD), according to a Phase II late-breaking clinical trial presented May 17 at the International Conference of Non-Invasive Cardiovascular Imaging (ICNC) in Amsterdam.
|
|
|
|
RSS 
